Literature DB >> 35369334

Case Report: Residual Atrial Shunt Lesions in Aging Adults With Congenital Heart Disease: An Underestimated Risk of Stroke?

Matthias Schneider1,2, Varius Dannenberg3, Bernd Opgen-Rhein4, Felix Berger2,4, Burkert Pieske1,2,5,6, Harald Gabriel3, Leif-Hendrik Boldt1,5.   

Abstract

We report two cases of paradoxical cerebral embolism in adults with congenital heart disease (ACHD) with residual atrial shunt lesions, a 59 year-old male patient with partial detachment of a surgical ASD closure patch, and a 57 year-old male patient with Ebstein's anomaly and a large patent foramen ovale. Considering these mechanisms and the increasing incidence of venous thrombosis with age, a higher prevalence of paradoxical embolism in ACHD patients with residual atrial shunts may be suspected. Regular follow-up of patients with ACHD remains important throughout life even in seemingly stable lesions.
Copyright © 2022 Schneider, Dannenberg, Opgen-Rhein, Berger, Pieske, Gabriel and Boldt.

Entities:  

Keywords:  ASD; Ebstein anomaly; adults with congenital heart disease; cardioembolic and cryptogenic stroke; case report; echocardiography; embolic stroke

Year:  2022        PMID: 35369334      PMCID: PMC8966378          DOI: 10.3389/fcvm.2022.847244

Source DB:  PubMed          Journal:  Front Cardiovasc Med        ISSN: 2297-055X


Introduction

The number of aging adults with congenital heart disease (ACHD) is constantly growing, as are late sequelae in this cohort (1). The risk for ischemic stroke is eleven times higher in young patients with CHD when compared to controls (2), the cumulative risk between the ages of 18 and 64 years is 6–8% (3). The majority of events occur in patients with cyanotic defects and in those without sinus rhythm (4). Arrhythmias are common in ACHD patients (5), in particular there is a high prevalence of atrial arrhythmias (6, 7). While paradoxical embolism via a patent foramen ovale (PFO) is associated with cryptogenic stroke in the general population and PFO closure reduces the rate of subsequent events in selected patients (8–10), up to now cryptogenic stroke has not been investigated systematically in ACHD patients.

Case Presentation

We report two cases of paradoxical cerebral embolism in ACHD patients with residual atrial shunt lesions (Figure 1). The first patient is a 59 year-old male who had received surgical repair of secundum atrial septum defect (ASD) 42 years ago. There were no regular follow-ups after the age of 30, his further medical history was unremarkable, exercise capacity was excellent. The patient presented to our hospital with acute embolic stroke. Transesophageal echocardiography revealed a residual atrial septal defect in the posterior inferior region due to partial detachment of the surgical patch (Figure 2) with spontaneous transfer of ultrasound contrast agent from right to left. The right ventricle was of borderline size, calculated Qp:Qs was 1.4:1. In absence of other reasons for embolic stroke (non-smoker, no dyslipidemia, no arterial hypertension, no history of atrial fibrillation, and unremarkable carotid ultrasound), paradoxical embolism was assumed and interventional closure of the residual atrial septum defect was performed with a 25 mm septal occluder device.
FIGURE 1

Timeline depicting the medical history of both presented patients. ASD, atrial septum defect.

FIGURE 2

Case 1, 59 year-old patient with a history of surgical ASD closure with partial detachment of the patch. Residual shunt shown by right-heart contrast agent (A), and by transesophageal echocardiography in 3D (B), 2D (C), and 2D color (D). ASD, atrial septum defect, RA, right atrium.

Timeline depicting the medical history of both presented patients. ASD, atrial septum defect. Case 1, 59 year-old patient with a history of surgical ASD closure with partial detachment of the patch. Residual shunt shown by right-heart contrast agent (A), and by transesophageal echocardiography in 3D (B), 2D (C), and 2D color (D). ASD, atrial septum defect, RA, right atrium. The second patient is a 57 year-old male with known Ebstein’s anomaly. Exercise capacity had been unchanged for years as were right heart dimensions. This patient also presented with embolic stroke. The patient was a non-smoker, there was no history of dyslipidemia, arterial hypertension, or atrial fibrillation, carotid ultrasound was unremarkable). TEE revealed a large PFO with spontaneous transfer of ultrasound contrast agent from right to left (Figure 3). Paradoxical embolism was assumed and the PFO was closed interventionally with a 25 mm PFO closure device. Exercise capacity remained unchanged after PFO closure.
FIGURE 3

Case 2, 57 year-old patient with Ebstein’s anomaly. A large PFO is shown via transesophageal echocardiography without (A) and with (B) color Doppler imaging. Interventional septal occluder implantation was performed, the result is shown in panels (C,D). PFO, patent foramen ovale, IAS, inter atrial septum, RA, right atrium.

Case 2, 57 year-old patient with Ebstein’s anomaly. A large PFO is shown via transesophageal echocardiography without (A) and with (B) color Doppler imaging. Interventional septal occluder implantation was performed, the result is shown in panels (C,D). PFO, patent foramen ovale, IAS, inter atrial septum, RA, right atrium. The two presented cases of paradoxical embolism illustrate that mechanisms of stroke in ACHD patients can be different from those of the general population (e.g., high right atrial pressure in Ebstein’s anomaly, large shunt in partial detachment of ASD patch). Considering these mechanisms and the increasing incidence of venous thrombosis with age (11), a higher prevalence of paradoxical embolism in ACHD patients with residual atrial shunts may be suspected and should be investigated in prospective trials.

Conclusion

With the increasing number of aging ACHD patients, late sequelae not directly related to the initial congenital heart disease significantly influence their morbidity and mortality. Regular follow-up of patients with ACHD remains important throughout life even in seemingly stable lesions.

Data Availability Statement

The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.

Author Contributions

MS: conceptualization and visualization. MS and VD: writing – original draft preparation. HG, VD, FB, BO-R, BP, and L-HB: writing – review and editing. BP, HG, and L-HB: supervision. All authors have read and agreed to the published version of the manuscript.

Conflict of Interest

HG was consultant for ABBOTT Medical and GORE Medical. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
  11 in total

1.  Congenital heart disease beyond the age of 60: emergence of a new population with high resource utilization, high morbidity, and high mortality.

Authors:  Oktay Tutarel; Aleksander Kempny; Rafael Alonso-Gonzalez; Richard Jabbour; Wei Li; Anselm Uebing; Konstantinos Dimopoulos; Lorna Swan; Michael A Gatzoulis; Gerhard-Paul Diller
Journal:  Eur Heart J       Date:  2013-07-23       Impact factor: 29.983

2.  Cerebrovascular accidents in adult patients with congenital heart disease.

Authors:  A Hoffmann; P Chockalingam; O H Balint; A Dadashev; K Dimopoulos; R Engel; M Schmid; M Schwerzmann; M A Gatzoulis; B Mulder; E Oechslin
Journal:  Heart       Date:  2010-08       Impact factor: 5.994

3.  Implantable loop recorder for monitoring patients with congenital heart disease.

Authors:  Michael Huntgeburth; Christopher Hohmann; Harald Kaemmerer; Christof Kolb; Peter Ewert; Sebastian Freilinger; Nicole Nagdyman; Rhoia Neidenbach; Lars Pieper; Felix Pieringer; Carsten Lennerz
Journal:  Cardiovasc Diagn Ther       Date:  2021-12

Review 4.  Anticoagulation management in adult patients with congenital heart disease: a narrative review.

Authors:  Christoph Sinning; Elvin Zengin; Gerhard Diller; Paulus Kirchhof; Stefan Blankenberg; Carsten Rickers; Yskert von Kodolitsch
Journal:  Cardiovasc Diagn Ther       Date:  2021-12

5.  Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke.

Authors:  Lars Søndergaard; Scott E Kasner; John F Rhodes; Grethe Andersen; Helle K Iversen; Jens E Nielsen-Kudsk; Magnus Settergren; Christina Sjöstrand; Risto O Roine; David Hildick-Smith; J David Spence; Lars Thomassen
Journal:  N Engl J Med       Date:  2017-09-14       Impact factor: 91.245

6.  Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke.

Authors:  Jean-Louis Mas; Geneviève Derumeaux; Benoît Guillon; Evelyne Massardier; Hassan Hosseini; Laura Mechtouff; Caroline Arquizan; Yannick Béjot; Fabrice Vuillier; Olivier Detante; Céline Guidoux; Sandrine Canaple; Claudia Vaduva; Nelly Dequatre-Ponchelle; Igor Sibon; Pierre Garnier; Anna Ferrier; Serge Timsit; Emmanuelle Robinet-Borgomano; Denis Sablot; Jean-Christophe Lacour; Mathieu Zuber; Pascal Favrole; Jean-François Pinel; Marion Apoil; Peggy Reiner; Catherine Lefebvre; Patrice Guérin; Christophe Piot; Roland Rossi; Jean-Luc Dubois-Randé; Jean-Christophe Eicher; Nicolas Meneveau; Jean-René Lusson; Bernard Bertrand; Jean-Marc Schleich; François Godart; Jean-Benoit Thambo; Laurent Leborgne; Patrik Michel; Luc Pierard; Guillaume Turc; Martine Barthelet; Anaïs Charles-Nelson; Christian Weimar; Thierry Moulin; Jean-Michel Juliard; Gilles Chatellier
Journal:  N Engl J Med       Date:  2017-09-14       Impact factor: 91.245

7.  Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke.

Authors:  Jeffrey L Saver; John D Carroll; David E Thaler; Richard W Smalling; Lee A MacDonald; David S Marks; David L Tirschwell
Journal:  N Engl J Med       Date:  2017-09-14       Impact factor: 91.245

8.  Stroke in Adults With Congenital Heart Disease: Incidence, Cumulative Risk, and Predictors.

Authors:  Jonas Lanz; James M Brophy; Judith Therrien; Mohammed Kaouache; Liming Guo; Ariane J Marelli
Journal:  Circulation       Date:  2015-11-23       Impact factor: 29.690

9.  Ischemic Stroke in Children and Young Adults With Congenital Heart Disease.

Authors:  Zacharias Mandalenakis; Annika Rosengren; Georgios Lappas; Peter Eriksson; Per-Olof Hansson; Mikael Dellborg
Journal:  J Am Heart Assoc       Date:  2016-02-23       Impact factor: 5.501

10.  Increasing age and atrial arrhythmias are associated with increased thromboembolic events in a young cohort of adults with repaired tetralogy of Fallot.

Authors:  Clara Tsui; Darryl Wan; Jasmine Grewal; Marla Kiess; Amanda Barlow; Derek Human; Santabhanu Chakrabarti
Journal:  J Arrhythm       Date:  2021-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.